Summary of Key Points Core Viewpoint The report outlines the use of raised funds by Xiangxin Technology Co., Ltd. to increase capital in its wholly-owned subsidiaries for the implementation of investment projects, confirming compliance with relevant regulations and the necessity for project advancement [1][10]. Group 1: Fundraising Overview - In 2020, the company issued convertible bonds totaling RMB 647,005,400, with a net amount raised of RMB 636,315,867.43 after expenses [1]. - In 2022, the company issued 26 million A-shares at RMB 33.69 per share, raising a total of RMB 875,940,000, with a net amount of RMB 863,087,203.80 after related costs [2]. Group 2: Investment Project Details - The 2020 bond issuance was allocated to a project for high-quality precision automotive molds and components, with a planned investment of RMB 64,700.54 million [3]. - The 2022 A-share issuance funds were adjusted for various projects, including the construction of production bases for energy storage and photovoltaic inverters [3]. Group 3: Capital Increase to Subsidiaries - The company plans to invest RMB 67,179,600 in Ningbo Xiangxin Precision Metal Structure Parts Co., Ltd., increasing its registered capital from RMB 150 million to RMB 180 million [4]. - An investment of RMB 50 million is planned for Guangzhou Xiangxin, raising its registered capital from RMB 230 million to RMB 250 million [4]. - Another RMB 50 million will be allocated to Yibin Xiangxin, increasing its registered capital from RMB 80 million to RMB 100 million [4]. Group 4: Subsidiary Information - Ningbo Xiangxin was established in May 2018, with a registered capital of RMB 150 million, focusing on automotive parts and metal products [5]. - Guangzhou Xiangxin, established in July 2017, has a registered capital of RMB 230 million, specializing in automotive engine manufacturing and related services [7]. - Yibin Xiangxin, founded in September 2021, is involved in battery manufacturing and automotive parts development [9]. Group 5: Approval and Compliance - The independent directors and board of supervisors have reviewed and approved the capital increase, confirming compliance with legal and regulatory requirements [10][11]. - The sponsor institution has verified that the capital increase aligns with the company's operational needs and does not harm shareholder interests [12].

| 证券代码：688013 证券简称：天臣医疗 公告编号：2025-048 | | | | | --- | --- | --- | --- | | 天臣国际医疗科技股份有限公司 | | | | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 | | | | | 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 | | | | | 根据中国证券监督管理委员会《上市公司募集资金监管规则》和《上海证券 | | | | | 交易所科创板上市公司自律监管指引第 1 号——规范运作》及相关格式指引等有 | | | | | 关规定，天臣国际医疗科技股份有限公司（以下简称"天臣医疗"、"公司"或"本 | | | | | 公司"）董事会编制了 2025 年半年度募集资金存放与实际使用情况专项报告。 | | | | | 一、募集资金基本情况 | | | | | （一）实际募集资金金额及到账时间 | | | | | 天臣医疗经中国证券监督管理委员会《关于同意天臣国际医疗科技股份有限 | | | | | 公司首次公开发行股票注册的批复》（证监许可[2020]2020 号）核准，公司向社 | ...

Summary of Key Points Core Viewpoint The company, Shida Shenghua New Materials Group Co., Ltd., is utilizing raised funds to provide loans to its subsidiaries for the implementation of investment projects, which has been approved by the board and supervisory committee, ensuring compliance with relevant regulations and protecting shareholder interests [1][8][9]. Fundraising Overview - The company received approval from the China Securities Regulatory Commission for a stock issuance, with a total fundraising amount not exceeding RMB 1,990 million [1]. - The actual net amount raised was RMB 982,169,508.71 after deducting issuance costs [1][2]. Investment Project Funding - The adjusted total amount for investment projects is RMB 982,169,508.71 [2]. - The company plans to allocate RMB 70 million to its wholly-owned subsidiary, Shenghua New Energy Technology (Dongying) Co., Ltd., for a project with an annual production capacity of 11,000 tons of additives [6][8]. - RMB 130 million will be provided to the controlling subsidiary, Dongying Shida Shenghua New Energy Co., Ltd., for a project with an annual production capacity of 100,000 tons of liquid lithium salt [6][8]. - RMB 482,169,508.71 will be allocated to Shenghua New Energy Technology (Wuhan) Co., Ltd. for a project with an annual production capacity of 220,000 tons of lithium battery materials [6][8]. Loan Management and Compliance - The loans will be issued based on project needs, with interest rates reflecting the company's average financing costs [7]. - A tripartite supervision agreement has been signed to ensure proper management of the raised funds [7]. - The company will adhere to regulations regarding the use of raised funds, ensuring no alteration of intended use that could harm shareholder interests [7][9]. Approval Process - The board of directors and the supervisory committee have both approved the use of raised funds for loans to subsidiaries, confirming compliance with regulatory requirements [8][9]. - The sponsor has verified that the process followed necessary procedures and does not harm shareholder interests [9].

证券代码：603085 证券简称：天成自控 公告编号：2025-057 浙江天成自控股份有限公司 第五届董事会第二十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 具 体 内 容 详 见 公 司 2025 年 8 月 26 日 在 上 海 证 券 交 易 所 网 站 （www.sse.com.cn）披露的《浙江天成自控股份有限公司 2025 年半年度报告》 全文及其摘要。 本议案已经公司董事会审计委员会审议通过。 表决结果：7 票同意，0 票反对，0 票弃权。 （二）审议通过《2025 年半年度募集资金存放与实际使用情况的专项报告》 具 体 内 容 详 见 公 司 2025 年 8 月 26 日 在 上 海 证 券 交 易 所 网 站 （www.sse.com.cn）披露的《浙江天成自控股份有限公司 2025 年半年度募集资 金存放与实际使用情况的专项报告》（公告编号：2025-059）。 本议案已经公司董事会审计委员会审议通过。 浙江天成自控股份有限公司（以下简称"公司"）第五届董事 ...

证券代码：300037 证券简称：新宙邦 公告编号：2025-061 债券代码：123158 债券简称：宙邦转债 深圳新宙邦科技股份有限公司 第六届董事会第二十四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 深圳新宙邦科技股份有限公司（以下简称"公司"）第六届董事会第二十四 次会议于2025年8月22日在公司会议室以现场结合通讯方式召开。本次董事会会议 通知已于2025年8月11日以电子邮件方式发出。本次董事会以现场方式参会董事5 人，以通讯方式参会董事4人，实际参与表决董事9人，公司监事和高级管理人员 列席会议。会议由公司董事长覃九三先生召集并主持。本次会议的召集、召开符 合有关法律、法规和《公司章程》的规定。 三、审议通过了《关于 <公司 ensp="ensp" 年半年度安全生产专题报告="年半年度安全生产专题报 告"> 的议案》 董事会审议了公司 EHS 中心提交的《公司 2025 年半年度安全生产专题报告》， 讨论并同意公司 2025 年上半年安全生产工作总结及 2025 年下半年 EHS 重点工 作和目标，全面落实企业安全生产主体责 ...

Group 1 - The board of directors of Hangxiao Steel Structure Co., Ltd. held its third meeting of the ninth session on August 25, 2025, via communication voting, with all seven directors present [1] - The meeting approved the full and summary report for the first half of 2025, which was reviewed by the audit committee and submitted for board approval, with a unanimous vote of 7 in favor [2][3] - The board also approved a special report on the storage and actual use of raised funds for the first half of 2025, which was similarly reviewed and received unanimous approval [2][3] Group 2 - The profit distribution plan for the first half of 2025 was approved, proposing a cash dividend distribution of 10 yuan for every 10 shares, excluding shares held in the company's repurchase account, which totals 9,997,714 shares [3] - The proposal for convening the third extraordinary general meeting of shareholders in 2025 was also approved, with unanimous support from the board [3]

Fundraising Overview - The company raised a total of RMB 113,511.12 million from the issuance of 17 million shares at a price of RMB 73.33 per share, with an oversubscription amount of RMB 1,566.33 million [1] - The funds have been verified and are fully in place as of July 12, 2023, by Rongcheng Accounting Firm [1] Fund Management - The company has established a dedicated account for the management of the raised funds and signed a tripartite supervision agreement with the sponsor and the bank [2] Use of Remaining Oversubscription Funds - The company plans to use RMB 33.10 million of the remaining oversubscription funds to permanently supplement its working capital, which aligns with its operational needs and benefits all shareholders [5][7] - After this allocation, the balance of the oversubscription account will be zero, and the company will cancel the relevant dedicated fund account [5] Compliance and Commitments - The company commits that the amount used for working capital will not exceed 30% of the total oversubscription funds within any 12-month period and will not engage in high-risk investments or provide financial assistance to others within 12 months after the fund allocation [5][6] Approval Process - The proposal for using the remaining oversubscription funds has been approved by the company's board of directors and supervisory board, and it will be submitted for review at the upcoming extraordinary shareholders' meeting [6][7] Supervisory Board Opinion - The supervisory board agrees that the use of remaining oversubscription funds for working capital meets legal requirements and does not conflict with the implementation of fundraising projects, fulfilling the company's operational liquidity needs [7] Sponsor's Verification - The sponsor has verified that the proposal has been duly approved by the board and supervisory board, and it complies with relevant regulations regarding the use of fundraising [7]

一、董事会会议召开情况 证券代码：605388 证券简称：均瑶健康 公告编号：2025-047 湖北均瑶大健康饮品股份有限公司 第五届董事会第十六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 表决结果：同意：9 票，反对：0 票，弃权：0 票。 此议案经第三届审计委员会第十一次会议审议通过。 特此公告。 湖北均瑶大健康饮品股份有限公司董事会 湖北均瑶大健康饮品股份有限公司（以下简称"公司"）第五届董事会第 十六次会议于 2025 年 8 月 22 日下午在公司会议室以现场结合通讯会议方式召 开，本次会议通知于 2025 年 8 月 12 日以电子邮件形式送达公司全体董事。本次 会议由公司董事长王均豪先生主持。会议应出席董事 9 人，实际出席董事 9 人， 公司监事和高级管理人员列席了本次会议。本次会议的召开符合《公司法》和《公 司章程》等有关规定。 二、董事会会议审议情况 表决结果：同意：9 票，反对：0 票，弃权：0 票。 此议案经第三届审计委员会第十一次会议审议通过。 （二）审议通过《关于 2025 年半 ...

Meeting Overview - The second meeting of the second board of Zhejiang Biyi Electric Co., Ltd. was held on August 25, 2025, with all 9 directors present [1] - The meeting was chaired by Chairman Wen Jiwang and complied with relevant laws and regulations [1] Resolutions Passed - The board approved the 2025 semi-annual report and summary, with details available on the Shanghai Stock Exchange website [2] - The board also approved the special report on the storage and actual use of raised funds for the first half of 2025, with details available on the Shanghai Stock Exchange website [2] - A resolution to amend the company's articles of association and handle business registration changes was passed, pending shareholder approval [3][4] - The board approved the proposal to abolish the supervisory board, transferring its legal powers to the audit committee, with relevant rules being abolished [3][5] - The board approved amendments to several governance systems in accordance with the new Company Law and relevant regulations [5][6] - A resolution to repurchase and cancel a portion of restricted stock due to the departure of two incentive targets was passed, with 8,400 shares to be repurchased [6][7] - The board decided to convene the fourth extraordinary general meeting of shareholders in 2025 [7]

Core Viewpoint - The board of Shanghai New Power Automotive Technology Co., Ltd. held its second meeting of the 11th session, where several key resolutions were passed regarding internal control evaluations, fundraising reports, project delays, and risk assessments [1][2][3] Group 1: Internal Control and Fundraising - The internal control evaluation report for the first half of 2025 was approved unanimously by the board [1] - A special report on the storage and actual use of the company's fundraising for the first half of 2025 was also approved [1] Group 2: Project Delays and Suspensions - The board agreed to postpone the "D25 high-performance diesel engine WGT project," "12VK power station product development project," and "new energy electric drive bridge product project" with new completion dates set for May 2026, August 2025, and July 2026 respectively [2] - The construction of the "new generation intelligent heavy truck" fundraising investment project by SAIC Hongyan was suspended [2] Group 3: Financial and Risk Assessments - The half-year report for 2025 was approved by the board [2] - A risk assessment report for SAIC Finance Company for the first half of 2025 was recognized and approved by the board and independent directors [2]